19-7916472-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001195259.2(TGFBR3L):c.205G>A(p.Asp69Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000032 in 1,529,964 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001195259.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBR3L | NM_001195259.2 | c.205G>A | p.Asp69Asn | missense_variant | Exon 1 of 6 | ENST00000565886.2 | NP_001182188.1 | |
TGFBR3L | NM_001419781.1 | c.133G>A | p.Asp45Asn | missense_variant | Exon 2 of 7 | NP_001406710.1 | ||
TGFBR3L | XM_011527610.3 | c.205G>A | p.Asp69Asn | missense_variant | Exon 1 of 4 | XP_011525912.1 | ||
TGFBR3L | XM_011527613.3 | c.205G>A | p.Asp69Asn | missense_variant | Exon 1 of 5 | XP_011525915.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 151976Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00000780 AC: 1AN: 128148Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 70222
GnomAD4 exome AF: 0.00000798 AC: 11AN: 1377874Hom.: 0 Cov.: 31 AF XY: 0.00000589 AC XY: 4AN XY: 678874
GnomAD4 genome AF: 0.000250 AC: 38AN: 152090Hom.: 1 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.205G>A (p.D69N) alteration is located in exon 1 (coding exon 1) of the TGFBR3L gene. This alteration results from a G to A substitution at nucleotide position 205, causing the aspartic acid (D) at amino acid position 69 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at